A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals

Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
10/2002
10/24/2002	WO2002084297A1 Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders
10/24/2002	WO2002084281A1 Encapsulated cell indicator system
10/24/2002	WO2002084280A1 Insect ammunition vectors and methods of use to identify pesticide targets
10/24/2002	WO2002083946A1 Method of examining allergic disease
10/24/2002	WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/24/2002	WO2002083921A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	WO2002083919A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
10/24/2002	WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	WO2002083898A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	WO2002083897A1 Transgenic non-human animals for pharmacological and toxicological studies
10/24/2002	WO2002083891A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
10/24/2002	WO2002083860A2 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/24/2002	WO2002083838A2 Elimination of endogenous porcine retrovirus
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083184A2 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
10/24/2002	WO2002083182A2 The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification
10/24/2002	WO2002083068A2 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
10/24/2002	WO2002082892A2 Automatic system-based animal training device
10/24/2002	WO2002067665A3 Cloning of transgenic animals comprising artificial chromosomes
10/24/2002	US20020157127 Transgene that comprises DNA encoding for epitope tagged TATA box binding protein (TBP), production of transgenic animals which express epitope-tagged TBP and use of epitope tagged TBP for isolating and affinity purifying transcription factors
10/24/2002	US20020157126 Transgenic nonhuman animal whose genome contains a nucleic acid sequence comprising a truncated Activin Type II receptor gene and a muscle-specific promoter operably linked and integrated into genome of animal; increased muscle mass
10/24/2002	US20020157125 Growth differentiation factor-8
10/24/2002	US20020157124 Transgenic rodents and rodent cell lines expressing HIV co-receptors
10/24/2002	US20020157123 Compositions and methods for treating enzyme deficiency
10/24/2002	US20020157121 Propagation of human hepatocytes in non-human animals
10/24/2002	US20020157118 Human neurofilament genes may be introduced into such genetically non-human animals to produce improved models of physiology of human neurofilament proteins which may be used to study human neurodegenerative disorders
10/24/2002	US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto
10/24/2002	US20020156001 Novel fibroblast growth factor ( FGF23) and methods for use
10/24/2002	US20020155998 Erythropoietin analog-human serum albumin fusion
10/24/2002	US20020155572 Peptide for use in diagnosis and treatment of alzheimier's disease
10/24/2002	US20020155453 Method for generating diversity
10/24/2002	US20020155100 Compositions and methods for regulated protein expression in gut
10/24/2002	CA2445990A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	CA2444451A1 Transgenic non-human animals for pharmacological and toxicological studies
10/24/2002	CA2443984A1 Encapsulated cell indicator system
10/24/2002	CA2443923A1 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
10/24/2002	CA2443736A1 Insect ammunition vectors and methods of use to identify pesticide targets
10/24/2002	CA2443147A1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	CA2443123A1 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	CA2443088A1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
10/24/2002	CA2442819A1 Elimination of endogenous porcine retrovirus
10/24/2002	CA2438107A1 G-protein coupled receptor molecules and uses thereof
10/23/2002	EP1250594A1 Swine defective for transmission of porcine endogenous retrovirus and uses thereof
10/23/2002	EP1250449A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals
10/23/2002	EP1250434A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
10/23/2002	EP1250418A2 Methods for identifying anti-cancer drug targets
10/23/2002	EP1250155A1 Angiogenesis and vascular permeability modulators and inhibitors
10/23/2002	EP1250060A2 Rearing of aquatic species with dha-rich prey organisms
10/23/2002	EP1250059A2 Cultivation of dha-rich prey organisms for aquatic species
10/23/2002	EP1250039A1 Transgenic goat producing milk containing human granulocyte-colony stimulating factor
10/23/2002	EP1056336A4 Selection of mature sperm by surface membrane determinants
10/23/2002	EP1003839A4 Methods for producing transgenic large mammals
10/23/2002	EP0996707A4 Transgenic animal with recombinant vascular endothelial growth factor b (vegf-b) dna and uses thereof
10/23/2002	CN1376196A Method for generating immune-compatible cells and tissues using nuclear transfer techniques
10/23/2002	CN1375196A Dove domesticating method
10/22/2002	US6469229 Inbred miniature swine and uses thereof
10/22/2002	US6469144 Apo-2li (apo-2 ligand inhibitor, related to apoptosis) monoclonal antibodies
10/22/2002	US6468798 Liposome-nucleic acid complexes are prepared then delivered via aerosol to the lung airway; for transforming pulmonary cells and treating lung diseases
10/22/2002	US6468791 Chromosone 1 gene and gene products related to Alzheimer's disease
10/22/2002	US6468771 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal DNA of target cells
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6467430 Apparatus for detecting estrus in livestock
10/22/2002	CA2188447C Recombinant poxviruses with foreign polynucleotides in essential regions
10/22/2002	CA2185712C Enhanced virus-mediated dna transfer
10/22/2002	CA2120655C Method of increasing the hatchability of eggs by feeding hens carnitine
10/20/2002	CA2382660A1 Method of detecting lesions such as cancer and inflammation in a transgenic mouse incorporating cytokine 3' untranslated region, using the instability of mrna
10/19/2002	CA2344512A1 Method of disposal of pet waste
10/17/2002	WO2002081747A1 Method of examining steroid responsiveness
10/17/2002	WO2002081741A2 Use of products of genes of the 2'-5' oligoadenylate synthetase family (oas) for screening antiviral agents and for detecting responsiveness to flaviviridae infection
10/17/2002	WO2002081737A2 Status of transmissible spongiform encephalopathies
10/17/2002	WO2002081715A1 A transgenic non-human animal having a disruption of at least one allele to the ceacam1 gene and method of making same
10/17/2002	WO2002081688A1 Dna molecules encoding igb3 synthase, and uses thereof for the disruption of glycosyltransferase genes in xenotransplantation tissues and organs
10/17/2002	WO2002081680A1 Method for producing transgenic teleost fish
10/17/2002	WO2002081677A2 Improved gene expression
10/17/2002	WO2002081494A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002	WO2002080851A2 Chimeric vaccines
10/17/2002	WO2002080663A1 Experimental animals for evaluation of therapeutic effects on corneal epithelial damages
10/17/2002	WO2002060924A3 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
10/17/2002	WO2002059140A3 Ikaros rgulatory elements and uses thereof
10/17/2002	WO2002046432A3 Modulating gene expression in insects by using double-stranded rna (dsrna)
10/17/2002	WO2002040700A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
10/17/2002	WO2002038607A3 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
10/17/2002	WO2002023983A3 Method of producing non-human mammals
10/17/2002	WO2002016417A3 Transgenic animal model for neurodegerative disease and uses thereof
10/17/2002	WO2002004489A9 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/17/2002	US20020152491 Methods and transgenic mouse model for identifying and modulating factors leading to motor neuron degeneration
10/17/2002	US20020152489 Transgenic organisms having tetracycline-regulated transcriptional regulatory systems
10/17/2002	US20020152487 Transgenic animal; controlling transcription factor; administering tetracyclic promoter
10/17/2002	US20020152484 Human t cell-engrafted mouse, method for developing same and use thereof
10/17/2002	US20020152481 Genetic engineering; qualitative analysis
10/17/2002	US20020152480 Alpha-synuclein super-mutants accelerate alpha-synuclein aggregation
10/17/2002	US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002	US20020151498 Medicaments that modify activity of Lipolysis Stimulated Receptor and that can be used to influence partitioning of dietary lipids between liver and peripheral tissues, including adipose tissue
10/17/2002	US20020151483 C3b/C4b complement receptor-like molecules and uses thereof
10/17/2002	US20020151463 Gene and polypeptide compositions in which expression of the agouti gene correlates with the development of insulin independent diabetes, hyperamylinemia, neoplasms and obesity
10/17/2002	US20020151022 Kinase capable of site-specific phosphorylation of IkappaBalpha
10/17/2002	US20020151015 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/17/2002	US20020150995 Methods for producing sialyloligosaccharides in a dairy source

1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 341